Keyphrases
Newborn Screening
100%
Gamma Markov Chain
83%
Congenital Athymia
83%
T-box Transcription Factor 1
83%
X-linked Severe Combined Immunodeficiency
83%
Diagnostic Challenge
83%
Therapeutic Approaches
83%
Hematopoietic Cell Transplantation
83%
Systemic Viral Infection
83%
Lifesaving
83%
Unrelated Donor
83%
Severe Combined Immunodeficiency
69%
Interleukin-2 Receptor alpha
55%
Genetic Testing
41%
Gene Therapy
41%
Thymus Transplantation
33%
Thymic Transplantation
33%
Life-threatening
33%
Haploinsufficiency
33%
22q11.2 Deletion Syndrome
33%
Hematopoietic Cell Transplant
33%
Viral Clearance
33%
Cytotoxic T Lymphocytes
33%
T Cell Lymphopenia
33%
Pathogenic Variants
27%
Non-coding
27%
Exon
27%
Multiple Variants
16%
Antiviral T Lymphocytes
16%
T-cell Receptor Excision Circles
16%
Newborn Period
16%
Immune Recovery
16%
Omenn Syndrome
16%
Chromosome 22
16%
Severe Infection
16%
Epithelial Development
16%
Anti-cytotoxic
16%
Allogeneic
16%
T Cell Immunity
16%
Early Diagnosis
16%
Immune Reconstitution
16%
Engraftment
16%
Definitive Therapy
16%
Clinical Syndromes
16%
Donor-derived
16%
Uncertain Significance
13%
Immune Parameters
13%
Adenosine Deaminase
13%
Most Common Form
13%
3′-untranslated Region (3′-UTR)
13%
Medicine and Dentistry
Fibrinogen
83%
Cell Transplantation
83%
Virus Infection
83%
T Box Transcription Factor
83%
Thymus Transplantation
83%
Hematopoietic Cell
83%
Cytotoxic T-Cell
41%
Transplantation
41%
Immune Reconstitution
41%
Lymphocytopenia
41%
T Cell
41%
Haploinsufficiency
41%
Viral Clearance
41%
Omenn Syndrome
20%
Early Diagnosis
20%
T Lymphocyte Receptor
20%
Newborn Period
20%
Infection
20%
Clinician
20%
Antivirus Agent
20%
Cellular Immunity
20%
Newborn Screening
20%
Chromosome 22
20%
Clinical Syndrome
20%
Engraftment
20%
Biochemistry, Genetics and Molecular Biology
Interleukin 2
83%
Newborn Screening
83%
Gene Therapy
62%
Genetic Screening
62%
Exon
41%
Adenosine Deaminase
41%
Untranslated Region
20%
X-Inactivation
20%
Genetic Disorder
20%
Promoter Region
20%
Intron
20%
Immunity
20%